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Polymorphism of G-174C in the interleukin-6 (IL-6) promoter could affect both the transcription and 
secretion of IL-6 and may be involved in inflammation related to and the pathogenesis of infectious 
diseases and chronic diseases. However, IL-6 G-174C polymorphism may differ in various ethnic 
groups. We recruited 300 Chinese healthy subjects among two ethnic populations in order to assess 
the nature of the IL-6 G-174C polymorphism in different ethnic populations of China. Common 
polymorphic loci in the IL-6 G-174C were determined by TaqMan SNP genotyping assays. We found 
that the C allele frequency at the -174 promoter region of IL-6 was extremely low in both Han and 
Uyghur ethnic groups. Therefore, it was concluded that the G to C variant at -174 of IL-6 is extremely 
rare in Chinese Han and Uyghur healthy populations, which are different from other American and 
African countries. 
 





Interleukin-6 (IL-6), one of the confirmed multifunctional 
pro-inflammatory cytokines which is demonstrated to be 
associated with infectious diseases (Jang et al., 2004; 
Nagabhushanam et al., 2003; Boulware et al., 2011; 
Sobti et al., 2010; Ruff et al., 2007; Newsom-Davis et al., 
2004; Poudrier et al., 2001) and cardiovascular diseases 
(Pola et al., 2003; Lalouschek et al., 2006; Hojo et al., 
2002; Plutzky, 2001; Tentolouris et al., 2004; Jenny et al., 
2002), tuberculosis, AIDS and stroke, have been given 
more and more attentions by researchers. IL-6 
demonstrates a crucial role in anti-viral immunity and in 
modulating T and B cell responses. Therefore, it can be 
conceived that the development of neutralizing antibodies 
against any of these cytokines as a consequence of 
autoimmunity affects the cellular functions and clearance 
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diseases. In addition, IL-6- deficient mice have been 
shown to be susceptible to various bacterial infections, 
including Mycobacterium, Streptococcus pneumoniae, 
Pseudomonas aeruginosa and Klebsiella pneumoniae 
(van der Poll et al., 1997; van Enckevort et al., 2001; 
Diao and Kohanawa, 2005) 
It is well established that IL-6 is also a key mediator in 
the inflammatory response associated with athero-
sclerosis and thus involved in many cardiovascular 
diseases, with many studies suggesting IL-6 may play a 
central role in the inflammatory response to cerebral 
ischemia, carotid artery atherosclerosis and coronary 
heart disease (Lalouschek et al., 2006; Hojo et al., 2002; 
Plutzky, 2001). The change from glycine (G) to cytosine 
(C) at position 174 of the IL-6 gene creates a potential 
binding site for the transcription factor NF-1, resulting in 
repressed gene expression. The G allele, on the other 
hand, is associated with higher circulating IL-6 levels 
(Fishman et al., 1998). IL-6 G-174C has been confirmed 
to be an important risk biomarker for some diseases such 
as   stroke,   cancer,  mental  retardation  and  ankylosing




Table 1. IL-6 genotypes and allele distribution among two ethnic groups. 
 
Parameter Han (n = 200) Uyghur (n = 100) P Value 
Age(years) 63.20 ± 10.35 63.18 ± 10.19 >0.05 
Sex(M/F) 105/95 52/48 >0.05 
    
IL-6 (-174)    
GG 199 98  
GC 1 2 >0.05 
CC 0 0  
    
IL-6 alleles    
G 399 198  
C 1 2 >0.05 
MAF 0.25 % 1 .00%  
 




spondylitis (Pola et al., 2003; Jenny et al., 2002; 
Gangwar et al., 2009; Resch et al., 2009; Collado-
Escobar et al., 2000). We detected this important 
polymorphism in Chinese Han and Uyghur populations, 
which are the first and sixth largest ethnic populations in 
China, respectively. The goal of the study was to 
determine whether the IL-6 G-174C polymorphism differ 
in various ethnic population in different countries.  
 
 




This study was carried out with prior approval from the local Ethics 
Committee. Three hundred healthy subjects examined in hospitals 
with detailed medical routine check-up report were enrolled from 
Shenzhen and Xinjiang. All subjects were given informed consents. 
The health condition conformed to the national stipulation physical 
examination standard. Subjects with a history or family history of 
hypertension, diabetes, stroke, cancer and chronic inflammatory 
disorders were excluded from the study.  
 
 
Sample processing  
 
After obtaining informed consent from these groups, 5 ml blood 
samples were taken in ethylenediamine tetraacetic acid (EDTA) and 
plain vials. Genomic DNA was extracted from the peripheral blood 
leukocyte pellet using a DNA extraction kit (AXYGEN, California, 
USA). DNA samples were stored at -80°C before use. 
 
 
Genotyping of the IL-6 promoter genomic variants 
 
The polymorphisms of IL-6 G-174C were determined using a 
TaqMan single nucleotide polymorphism (SNP) genotyping 
technique. The IL-6 -174G/C primers were forward, 5′-
AGCCTCAATGACGACCTAAG-3′ and reverse, 5′-
GGGGCTGATTGGAAACCTTA-3′. The TaqMan minor groove 
binding (MGB) probes for detection of G/C polymorphism 
(rs1800795) were FAM-AGTTGTGTCTTGCGATGC–MGB and 
HEX- AGTTGTGTCTTGCCATGC-MGB.  The  primers  and  probes 
were commercially supplied by Shanghai GeneCore Biotech-
nologies. Thermal cyclings were performed on, and allele 
frequencies were determined by Stratagene Mx4000 systems 
(Stratagene, La Jolla, CA, USA). 
Comparisons between Han and Uyghur populations were made 
with the Fisher’s exact test (nominal data). The statistical analysis 
was carried out using SPSS software package SPSS12.0 (SPSS 
Inc., Chicago, Illinois, USA). A meta-analysis was done to test 
heterogeneity between different populations. The Q statistic test 
was used to assess heterogeneity, in which a P value greater than 
0.05 suggested a lack of heterogeneity. All statistic analyses were 
done with Stata Statistical Package (version 10.0). To improve the 
genotyping quality and validate our results, a random selection of 
10% of the samples were re-genotyped and ten randomly selected 
simples were re-sequenced by laboratory personnel not otherwise 
involved in the study, and the results were found to be reproducible 
with no discrepancies noted. 
 
 
RESULTS AND DISCUSSION 
 
Table 1 includes the demographic and clinical charac-
teristics of the patients and controls from the Han and 
Uyghur populations. The ratio of males to females was 
105:95 in the Han subjects and 52:48 in the Uyghur 
subjects. There were no significant differences in sex 
between two populations (P>0.05). In addition, Table 1 
also shows the distributions of the genotypes and allelic 
frequencies of IL-6 -174G/C polymorphisms in the 
Chinese Han and Uyghur population. There were no 
statistically significant differences in the distribution of IL-
6 G-174C polymorphism between two either ethnic group 
(P>0.05). The C allele frequencies at the -174 promoter 
region of IL-6 were extremely low in both the Chinese 
Han and Uyghur populations. Figure 1 compares the IL-6 
G-174C genotype frequency distribution between various 
populations, including Asian population, Caucasians and 
Blacks from American, African, Gujarat and Spanish (Cox 
et al., 2001; Collado-Escobar et al., 2000). The results 
among Han and Uyghur are very different from 
Caucasians and  Blacks  (P<0.05).  The  results  of meta-






IL-6 -174G/C genotype frequency distribution between various 
populations. 
    Compared with Han population; P<0.05.   




analysis were also featured with strong heterogeneity 




IL-6, one of the most important mediators in in vivo 
inflammatory reactions, is implicated in the development 
of many inflammatory diseases (Jang et al., 2004; 
Nagabhushanam et al., 2003; Boulware et al., 2011; 
Sobti et al., 2010; Ruff et al., 2007; Newsom-Davis et al., 
2004; Poudrier et al., 2001; Pola et al., 2003; Lalouschek 
et al., 2006; Hojo et al., 2002). There are also mounting 
evidences confirming that IL-6 is a key regulator of 
inflammatory mechanisms that play an important role in 
the pathophysiology and development of autoimmune 
disease (Maddur et al., 2010). A part of the single-
nucleotide polymorphisms (SNPs) identified in the IL-6 
gene, especially within the non-coding promoter 
sequence has been shown to have a powerful influence 
on the expression of the gene (Fishman et al., 1998).  
Our study shows the distribution of a significant SNP 
(G-174C) of IL-6 in Chinese Han and Uyghur population. 
The Uyghur population, a minority group originated from 
Turkish nomads living in Xinjiang having language, 
religious beliefs and lifestyles that may be very different 
from either Han population or American/European 
populations, is a special population presenting the typical 
admixture of Eastern and Western anthropometric traits 
in china. A study has shown that the Uyghur population 
has 60% European ancestry and 40% East Asian 
ancestry (Xu et al., 2008). 
Some previous studies have found a unique 
association between the CC genotype of the G-174C IL-6 
polymorphism and many important  diseases  (Pola et al., 
2003; Jenny et al., 2002). Recently, the G-174C promoter 
polymorphism has been linked with increased risk of 
cervical cancer and developmental delay (Gangwar et al., 
2009; Resch et al., 2009). However, we found the 
distribution of this functional polymorphism of G-174C in 
the IL-6 is different from other populations. Interestingly, 
we found that the C allele frequency at the -174 promoter 
region of IL-6 was extremely low in the both Han and 
Uyghur population. The meta-analysis findings also 
suggest to us that there may be genetic backgrounds 
variations between different countries that may affect the 
risk of diseases. However, the reason for the rarity of C 
allele in the Chinese population is unclear and needs 
further ethnicity-specific studies. 
From the current study, we conclude that the C allele 
frequency at the -174 promoter region of IL-6 is extremely 
low in the Chinese Han and Uyghur population, which are 
very different from Caucasians and Blacks (Cox et al., 
2001; Collado-Escobar et al., 2000). These findings may 
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